BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31049328)

  • 1. Uveal Melanoma in Ireland.
    Baily C; O'Neill V; Dunne M; Cunningham M; Gullo G; Kennedy S; Walsh PM; Deady S; Horgan N
    Ocul Oncol Pathol; 2019 Apr; 5(3):195-204. PubMed ID: 31049328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uveal melanoma: relatively rare but deadly cancer.
    Kaliki S; Shields CL
    Eye (Lond); 2017 Feb; 31(2):241-257. PubMed ID: 27911450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uveal melanoma incidence and survival analysis in Portugal between 2013 and 2022.
    Geada S; Machado T; Teixeira T; Simões PC; Oliveiros B; da Luz Cachulo M; Fonseca C; Proença R
    Cancer Epidemiol; 2024 Jun; 90():102575. PubMed ID: 38663175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
    Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
    Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveal melanoma: trends in incidence, treatment, and survival.
    Singh AD; Turell ME; Topham AK
    Ophthalmology; 2011 Sep; 118(9):1881-5. PubMed ID: 21704381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter.
    Sabazade S; Herrspiegel C; Gill V; Stålhammar G
    BMC Cancer; 2021 Nov; 21(1):1270. PubMed ID: 34819035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of uveal melanoma in the United States: 1973-1997.
    Singh AD; Topham A
    Ophthalmology; 2003 May; 110(5):956-61. PubMed ID: 12750097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of uveal melanoma in Europe.
    Virgili G; Gatta G; Ciccolallo L; Capocaccia R; Biggeri A; Crocetti E; Lutz JM; Paci E;
    Ophthalmology; 2007 Dec; 114(12):2309-15. PubMed ID: 17498805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
    Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
    J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival from uveal melanoma in Western Australia 1981-2005.
    Chew AL; Spilsbury K; Isaacs TW
    Clin Exp Ophthalmol; 2015 Jul; 43(5):422-8. PubMed ID: 25556534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
    Frenkel S; Hendler K; Pe'er J
    Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uveal melanomas. Conservation treatment.
    Munzenrider JE
    Hematol Oncol Clin North Am; 2001 Apr; 15(2):389-402. PubMed ID: 11370500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1973-2013).
    Aronow ME; Topham AK; Singh AD
    Ocul Oncol Pathol; 2018 Apr; 4(3):145-151. PubMed ID: 29765944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe.
    Mallone S; De Vries E; Guzzo M; Midena E; Verne J; Coebergh JW; Marcos-Gragera R; Ardanaz E; Martinez R; Chirlaque MD; Navarro C; Virgili G;
    Eur J Cancer; 2012 May; 48(8):1167-75. PubMed ID: 22119735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
    Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
    Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.